Clinical trials in India
Clinical trials and research are a critical part of bringing new medicines to patients. Through the data generated from clinical trials, we answer important scientific questions and gain a better understanding about the efficacy and safety of these study medicines and their potential as treatment options for patients.
Improving the global clinical trial footprint in India
Bristol Myers Squibb is united by our mission to transform patients' lives through science by discovering, developing and delivering innovative medicines that help prevail over serious diseases. To that end, the company is committed to doing its part to help ensure patients achieve optimal health outcomes.
We are working to improve the recruitment of diverse patients with the goal that the clinical trial population becomes more reflective of the real-world population and the people impacted by the diseases studied.
More than 25 clinical trials encompassing therapeutic areas such as Oncology, Hematology, Cardiovascular, Immunosciences and Neuroscience are presently ongoing in India. The involvement of India in these global trials holds promising prospects for the future, as it will ultimately benefit patients within the country.
NO-IN-2400012
Expiry: 14 Nov. 2026